by Eriksen Insurance | Feb 24, 2025 | Uncategorized
In fiscal year 2024, the federal government allocated $1.9 trillion to health care programs and services, representing 27% of total federal expenditures and marking it as the largest category of federal spending. Additionally, tax subsidies for employer-sponsored...
by Eriksen Insurance | Feb 20, 2025 | Uncategorized
Recent research indicates that semaglutide, the active ingredient in Ozempic and Wegovy, may significantly reduce alcohol consumption in individuals with alcohol use disorder (AUD). A study published in JAMA Psychiatry involved 48 participants diagnosed with AUD. Over...
by Eriksen Insurance | Feb 19, 2025 | Uncategorized
The escalating costs of weight-loss medications, particularly GLP-1 drugs like Ozempic and Wegovy, are prompting several states to reconsider their coverage policies for state employees. In Colorado, expenditures on these medications have more than quadrupled from...
by Eriksen Insurance | Jul 24, 2019 | Affordable Care Act, Obamacare
The S HR M reports: “The U.S. House of Representatives voted on July 17 to abolish the so-called “Cadillac tax” on employer-sponsored high-value health plans, set to take effect in 2022. If the Senate passes the measure and the president signs it...
by Eriksen Insurance | Jul 24, 2019 | Affordable Care Act
KFF.org reports: “On July 9, 2019, the U.S. Court of Appeals for the 5th Circuit will hear oral argument in Texas v. U.S., the next round of litigation challenging the Affordable Care Act (ACA). The appeals court is reviewing a federal trial court’s decision...
